Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerstine Carter

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmaceutical Statistics|January 14, 2024
On "Re-randomization tests as sensitivity analyses to confirm immunological noninferiority of an investigational vaccine: Case study" by Luca Grassano et al. (2023, Pharmaceutical Statistics)Oleksandr Sverdlov, Vance W Berger, Kerstine Carter
Statistics in Medicine|June 4, 2024
Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi-center clinical trialJohannes Krisam, Yevgen Ryeznik, Kerstine Carter, et al.
BMC Medical Research Methodology|November 20, 2024
Correction: Forced randomization: the what, why, and howKerstine Carter, Olga Kuznetsova, Volodymyr Anisimov, et al.
Statistical Methods in Medical Research|July 24, 2025
To what extent is response-adaptive randomization used in clinical trials? A systematic review using Cortellis Regulatory Intelligence databaseOleksandr Sverdlov, Jone Renteria, Kerstine Carter, et al.
BMC Medical Research Methodology|October 8, 2024
Forced randomization: the what, why, and howKerstine Carter, Olga Kuznetsova, Volodymyr Anisimov, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 9, 2016
Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trialDaniel Dusser, Robert A Wise, Ronald Dahl, et al.
Statistics in Medicine|January 20, 2024
Steady-state statistical properties and implementation of randomization designs with maximum tolerated imbalance restriction for two-arm equal allocation clinical trialsWenle Zhao, Kerstine Carter, Oleksandr Sverdlov, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 3, 2018
Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR<sup>®</sup> trialRobert A Wise, Peter Ma Calverley, Kerstine Carter, et al.
BMC Medical Research Methodology|February 28, 2024
Selecting a randomization method for a multi-center clinical trial with stochastic recruitment considerationsOleksandr Sverdlov, Yevgen Ryeznik, Volodymyr Anisimov, et al.
The Lancet. Respiratory Medicine|April 2, 2018
Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trialPeter M A Calverley, Antonio R Anzueto, Kerstine Carter, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmaceutical Statistics|January 14, 2024
On "Re-randomization tests as sensitivity analyses to confirm immunological noninferiority of an investigational vaccine: Case study" by Luca Grassano et al. (2023, Pharmaceutical Statistics)Oleksandr Sverdlov, Vance W Berger, Kerstine Carter
Statistics in Medicine|June 4, 2024
Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi-center clinical trialJohannes Krisam, Yevgen Ryeznik, Kerstine Carter, et al.
BMC Medical Research Methodology|November 20, 2024
Correction: Forced randomization: the what, why, and howKerstine Carter, Olga Kuznetsova, Volodymyr Anisimov, et al.
Statistical Methods in Medical Research|July 24, 2025
To what extent is response-adaptive randomization used in clinical trials? A systematic review using Cortellis Regulatory Intelligence databaseOleksandr Sverdlov, Jone Renteria, Kerstine Carter, et al.
BMC Medical Research Methodology|October 8, 2024
Forced randomization: the what, why, and howKerstine Carter, Olga Kuznetsova, Volodymyr Anisimov, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 9, 2016
Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trialDaniel Dusser, Robert A Wise, Ronald Dahl, et al.
Statistics in Medicine|January 20, 2024
Steady-state statistical properties and implementation of randomization designs with maximum tolerated imbalance restriction for two-arm equal allocation clinical trialsWenle Zhao, Kerstine Carter, Oleksandr Sverdlov, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 3, 2018
Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR<sup>®</sup> trialRobert A Wise, Peter Ma Calverley, Kerstine Carter, et al.
BMC Medical Research Methodology|February 28, 2024
Selecting a randomization method for a multi-center clinical trial with stochastic recruitment considerationsOleksandr Sverdlov, Yevgen Ryeznik, Volodymyr Anisimov, et al.
The Lancet. Respiratory Medicine|April 2, 2018
Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trialPeter M A Calverley, Antonio R Anzueto, Kerstine Carter, et al.
Pageof 2